课题基金 / 基金详情

CAREER: Molecular Rhenium(V) Oxotransferases

CAREER: Molecular Rhenium(V) Oxotransferases
职业:分子铼(V) 氧化转移酶
批准号:
9874857
负责人:
Mahdi Abu-Omar
金额:
$33.15万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-15 至 2003-01-31

项目摘要

项目成果

Mahdi Abu-Omar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This CAREER award in the Inorganic, Bioinorganic, and Organometallic Chemistry Program supports research and education on oxygen transfer reactions by Dr. Mahdi M. Abu-Omar of the Chemistry Department, University of California - Los Angeles. New rhenium-based catalysts will be prepared and used to enhance the oxygen-transfer chemistry of sulfoxides. The catalytic reactions of complexes of the general formula ReOCl3LL' will be studied in detail using spectroscopic and kinetic methods. Density Functional Theory calculations on model systems will be used to understand the catalytic reactivities. Using the results, chiral Re(V) oxazoline complexes that are resistant to degradation will be designed in order to promote asymmetric oxo-transfer reactions. Efficient new catalysts will be developed for the asymmetric epoxidation of olefins by sulfoxides. The educational component of this CAREER Award will focus on incorporating contemporary research issues into undergraduate classes in inorganic chemistry and new approaches to problem sessions will be developed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAS: Catalytic funneling and upgrading of biomass-derived phenols and polyols
Catalytic Oxidations with Lignin-Based Ligands
Bioinspired and Sustainable Catalysis for Chlorite Conversion and Dioxygen Reduction
I-Corps: Sustainable manufacturing of natural vanillin
  • 批准号:
    1640315
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2016
  • 负责人:
    Mahdi Abu-Omar
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant